Screener
Aclaris Therapeutics ACRS Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Aclaris Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Aclaris Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-092065
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Revenues: | ||||
| Contract research | $356 | $442 | $893 | $887 |
| Licensing | 1,273 | 1,335 | 2,732 | 2,345 |
| Total revenue | 1,629 | 1,777 | 3,625 | 3,232 |
| Costs and expenses: | ||||
| Cost of revenue | 218 | 515 | 613 | 1,021 |
| Research and development | 18,066 | 11,449 | 33,723 | 23,033 |
| General and administrative | 6,048 | 5,386 | 12,791 | 11,525 |
Item 1. Financial Statements
FAQ
- What is Aclaris Therapeutics's total revenue?
- Aclaris Therapeutics (ACRS) reported total revenue of $1.63M in Q2 2026.
- How has Aclaris Therapeutics's total revenue changed year-over-year?
- Aclaris Therapeutics's total revenue decreased by 8.3% year-over-year, from $1.78M to $1.63M.
- What is the long-term trend for Aclaris Therapeutics's total revenue?
- Over 4 years (2021 to 2025), Aclaris Therapeutics's total revenue has grown at a 3.7% compound annual growth rate (CAGR), from $6.76M to $7.83M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Aclaris Therapeutics's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude